Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04895358
Brief Title: Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

First Submitted : May 17, 2021
First Submitted that Met QC Criteria : May 17, 2021
First Posted : May 20, 2021

Last Update Submitted that Met QC Criteria : August 11, 2022
Last Update Posted : August 12, 2022 (Estimate)